NCT01461668View on ClinicalTrials.gov

Retapamulin for Reducing MRSA Nasal Carriage

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Methicillin-Resistant Staphylococcus Aureus
Interventions
DRUG

Retapamulin

Two times a day for 5 days

DRUG

Placebo

Two times a day for 5 days

Trial Locations (1)

92617

University of California, Irivne, Irvine

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

University of California, Irvine

OTHER

NCT01461668 - Retapamulin for Reducing MRSA Nasal Carriage | Biotech Hunter | Biotech Hunter